OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr. Wolkers did her PhD in Ton Schumacher’s lab. After her postdoctoral training with Stephen Schoenberger (La Jolla Institute), Douglas Green (St. Jude’s Memphis), and Jan-Paul Medema (AmsterdamUMC-AMC), Dr. Wolkers started her group in 2010 at Sanquin Research, Amsterdam. Since then, she is fascinated by the molecular mechanisms that dictate CD8 T-cell effector function. Her group showed for instance that post-transcriptional mechanisms define the production of pro-inflammatory cytokines and define their capacity to kill tumors and infected cells. Furthermore, her group uncovered surface markers that can distinguish cytotoxic from non-cytotoxic T cells, a tool that may be important for the development of effective T-cell therapies. Monika holds an ERC consolidator grant and is an Oncode Investigator.
